Ambeed.cn

首页 / 抑制剂/激动剂 / / / Monomethyl auristatin E

一甲基澳瑞他汀 E /Monomethyl auristatin E {[allProObj[0].p_purity_real_show]}

货号:A172961 同义名: MMAE;Vedotin

Monomethyl auristatin E(MMAE;SGD-1010)是杜氏素10的合成衍生物,通过抑制微管蛋白聚合而起到强效有丝分裂抑制剂的作用。MMAE广泛用于抗体-药物结合物(ADC)的细胞毒性成分,以治疗各种癌症。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Monomethyl auristatin E 化学结构 CAS号:474645-27-7
Monomethyl auristatin E 化学结构
CAS号:474645-27-7
Monomethyl auristatin E 3D分子结构
CAS号:474645-27-7
Monomethyl auristatin E 化学结构 CAS号:474645-27-7
Monomethyl auristatin E 3D分子结构 CAS号:474645-27-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Monomethyl auristatin E 纯度/质量文件 产品仅供科研

货号:A172961 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >

Monomethyl auristatin E 生物活性

描述 Monomethyl auristatin E (MMAE) produced under Good Manufacturing Practice (GMP) guidelines is a version of MMAE that inhibits tubulin polymerization[1].
体内研究

The combination of Monomethyl auristatin E (MMAE) with ionizing radiation (IR) leads to delayed tumor growth, whereas the use of tumor-targeting ACPP-cRGD-MMAE alongside IR results in a more pronounced and prolonged regression of tumors in xenograft models[2].

体外研究

Within CD30+ cancer cells, Monomethyl auristatin E (MMAE) is effectively liberated from SGN-35 and can kill adjacent non-targeted cells due to its ability to permeate cell membranes[1].

MMAE enhances the sensitivity of colorectal and pancreatic cancer cells to ionizing radiation (IR) in a manner that is both schedule and dose-dependent, which is associated with mitotic arrest. This increased radiosensitivity results in reduced clonogenic survival and a higher incidence of DNA double-strand breaks in cells subjected to irradiation[2].

作用机制 MMAE binds to tubulin and interferes with microtubule formation.[4]

Monomethyl auristatin E 动物研究

Dose Cynomolgus monkey: 0.3 mg/kg - 3 mg/kg[5] (i.v.) Rat: 0.03 mg/kg - 0.2 mg/kg[6] (i.v.) Mice: 0.3 mg/kg[7] (i.v.)
Administration i.v.

Monomethyl auristatin E 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02227199 Recurrent Adult Hodgkin Lympho... 展开 >>ma Refractory Hodgkin Lymphoma TNFRSF8 Positive 收起 << Phase 1 Phase 2 Recruiting - United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal    206-606-2037    agopal@u.washington.edu    Principal Investigator: Ajay K. Gopal 收起 <<
NCT00866047 - Completed - -
NCT02001623 Ovary Cancer ... 展开 >>Cervix Cancer Endometrium Cancer Bladder Cancer Prostate Cancer (CRPC) Esophagus Cancer Lung Cancer(NSCLC) Squamous Cell Carcinoma of the Head and Neck (SCCHN) 收起 << Phase 1 Phase 2 Active, not recruiting December 2018 -

Monomethyl auristatin E 参考文献

[1]Yang SY, Li LL. The purposes of 5H- [1,2,4] triazine [5,6-b] indole derivatives of 3 substitutions. CN108309982A. 2017.

[2]Lisa Buckel, et al. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery. Cancer Res. 2015 Apr 1;75(7):1376-87.

Monomethyl auristatin E 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.39mL

0.28mL

0.14mL

6.96mL

1.39mL

0.70mL

13.93mL

2.79mL

1.39mL

Monomethyl auristatin E 技术信息

CAS号474645-27-7
分子式C39H67N5O7
分子量 717.979
别名 MMAE;Vedotin;Brentuximab vedotin;SGD-1010
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Sealed in dry,2-8°C

溶解度

DMSO: 50 mg/mL(69.64 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

无水乙醇: 45 mg/mL(62.68 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。